Institutional Ownership
Lucid Diagnostics Inc
CUSIP 54948X109COMLUCDQ1 2026
13D / 13G Filings
12
Schedule 13D/13G on record
Beneficial Filers
2
Distinct reporting persons
Largest Stake
75.5%
Max % of class reported
Institutional Holders
98
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
12 filings · latest Feb 9, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 9, 2026 | Pavmed Inc. | 13D/A | 27.5% | — | SEC |
| 2 | Oct 10, 2025 | Pavmed Inc. | 13D/A | 28.3% | — | SEC |
| 3 | Feb 13, 2025 | Ayrton Capital LLC | 13G/A | 2.0% | 1.20M | SEC |
| 4 | Dec 12, 2024 | Pavmed Inc. | 13D/A | 52.7% | 31.30M | SEC |
| 5 | Jul 8, 2024 | Ayrton Capital LLC | 13G/A | 9.9% | 4.96M | SEC |
| 6 | Feb 20, 2024 | Pavmed Inc. | 13D/A | 65.2% | 31.30M | SEC |
| 7 | Feb 14, 2024 | Ayrton Capital LLC | 13G | 9.9% | 1.16M | SEC |
| 8 | Feb 2, 2024 | Pavmed Inc. | 13D/A | 72.2% | 34.63M | SEC |
| 9 | Mar 24, 2023 | Ayrton Capital LLC | 13G/A | 4.9% | 2.22M | SEC |
| 10 | Mar 23, 2023 | Ayrton Capital LLC | 13G | 10.0% | 4.82M | SEC |
2 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Lucid Diagnostics Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Blackrock, Inc. | 4.64M | $5.33M |
| 2 | Masters Capital Management LLC | 4.00M | $4.60M |
| 3 | Aberdeen Group PLC | 3.64M | $4.19M |
| 4 | Two Seas Capital LP | 3.00M | $3.45M |
| 5 | Geode Capital Management, LLC | 2.25M | $2.58M |
| 6 | Russell Investments Group, Ltd. | 1.58M | $1.82M |
| 7 | State Street Corp | 1.55M | $1.79M |
| 8 | Wells Fargo & Company/Mn | 1.27M | $1.47M |
| 9 | Perkins Capital Management Inc | 1.13M | $1.29M |
| 10 | Sunbelt Securities, Inc. | 900.0K | $1.04M |